About Symlux Pharmaceuticals
Symlux Pharmaceuticals was a Healthcare company based in Mumbai (India) founded in 2015. Manufacturer of syrup, powder, tablets, capsules, and semi-solid forms. It operates on a Traditional Pharmaceuticals model. The company is recorded as dissolved. Symlux Pharmaceuticals offers products and services including Symlux Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified. Its legal entity in India is Symlux Pharmaceuticals Private Limited (U74999MH2015PTC268271).
Company details
Symlux Pharmaceuticals manufacturer of syrup, powder, tablets, capsules, and semi-solid forms, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website symluxpharma.com
- Legal Name Symlux Pharmaceuticals Private Limited
- Date of Incorporation 09 Sep, 2015
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹18,370
FY 2023 · -77% YoY
- Net Loss-₹2,810
FY 2023 · -15% margin
- EBITDA₹6,570
FY 2023 · 36% margin
Associated legal entities of Symlux Pharmaceuticals
Symlux Pharmaceuticals operates through Symlux Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Symlux Pharmaceuticals Private Limited CIN U74999MH2015PTC268271 | Active | 09 Sep 2015 | Thane, Maharashtra | ₹0.0 Cr | 2 | View details |
Products & Services of Symlux Pharmaceuticals
Symlux Pharmaceuticals offers a comprehensive portfolio of products and services, including Symlux Pharmaceuticals Platform.
Manufacturer of syrup, powder, tablets, capsules, and semi-solid forms
Board of directors of Symlux Pharmaceuticals Private Limited (Symlux Pharmaceuticals)
Symlux Pharmaceuticals Private Limited is the primary company behind Symlux Pharmaceuticals. The board of Symlux Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Amol Ramdas Nilakh, appointed in 2015. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amol Ramdas Nilakh DIN 07304539 | Director | 19 Oct 2015 | 11 yrs | Symlux Pharmaceuticals Private Limited |
| Santosh Shrikrishna Joshi DIN 01670244 | Director | 23 Mar 2016 | 10 yrs 7 mo | Symlux Pharmaceuticals Private Limited |
Financials of Symlux Pharmaceuticals
Figures of Symlux Pharmaceuticals Private Limited, the primary company behind Symlux Pharmaceuticals, for FY 2023. Revenue was ₹18,370 (-77% year on year). Net loss was -₹2,810 (-15% margin). EBITDA was ₹6,570 (36% margin). Revenue has grown at a compounded annual rate of -73% over five years.
- ₹18,370Revenue · FY 2023 · -77% YoY
- -₹2,810Net loss · -15% margin
- ₹6,570EBITDA · 36% margin
- ₹1 LakhPaid-up capital
- -73%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Symlux Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Symlux Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Symlux Pharmaceuticals
Symlux Pharmaceuticals was founded in 2015.
Symlux Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Symlux Pharmaceuticals, Symlux Pharmaceuticals Private Limited, reported revenue of ₹18,370 for FY 2023, down 77% year on year.
Symlux Pharmaceuticals manufacturer of syrup, powder, tablets, capsules, and semi-solid forms, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Symlux Pharmaceuticals offers Symlux Pharmaceuticals Platform.
Symlux Pharmaceuticals operates through Symlux Pharmaceuticals Private Limited.
The legal entities of Symlux Pharmaceuticals currently have 2 directors, including Santosh Shrikrishna Joshi, Amol Ramdas Nilakh.